IOB - Delayed Quote USD
Bristol-Myers Squibb Company (0R1F.IL)
47.15
-1.05
(-2.18%)
As of 6:28:39 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
14,310,000
15,190,000
13,860,000
13,066,000
16,207,000
Investing Cash Flow
-2,233,000
-21,352,000
-2,295,000
-1,062,000
-538,000
Financing Cash Flow
-10,510,000
5,127,000
-9,416,000
-16,962,000
-16,224,000
End Cash Position
10,901,000
10,347,000
11,519,000
9,325,000
14,316,000
Capital Expenditure
-1,224,000
-1,248,000
-1,209,000
-1,118,000
-973,000
Issuance of Debt
384,000
15,969,000
4,455,000
6,120,000
0
Repayment of Debt
--
-5,873,000
-3,999,000
-11,431,000
-6,022,000
Repurchase of Capital Stock
--
0
-5,155,000
-8,001,000
-6,287,000
Free Cash Flow
13,086,000
13,942,000
12,651,000
11,948,000
15,234,000
12/31/2021 - 11/4/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4AB.BE AbbVie Inc
166.00
-1.54%
VIRP.PA Virbac SA
307.50
-0.13%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
51.20
-1.06%
RHHBY Roche Holding AG
38.34
-0.03%
NOV.DE Novo Nordisk A/S
59.00
+0.77%
GSK.L GSK plc
1,382.60
+1.81%
BIIB Biogen Inc.
123.16
-1.00%
AZN AstraZeneca PLC
67.72
-1.78%
AMGN Amgen Inc.
270.45
-1.57%
GILD Gilead Sciences, Inc.
101.43
-2.30%